Works by 石远凯

Results: 38

伊鲁阿克治疗间变性淋巴瘤激酶融合基因阳性局部晚期或转移性非小细胞肺癌中国专家共识（2024版）.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 3, p. 189, doi. 10.3760/cma.j.cn112152-20230901-00110

By:

石远凯

Publication type:

Article

肿瘤化疗导致的中性粒细胞减少诊治中国专家共识 (2023 版).

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 7, p. 575, doi. 10.3760/cma.j.cn112152-20230224-00076

By:

冯继锋;
石远凯;
沈波

Publication type:

Article

中国Ⅳ期原发性肺癌多学科团队诊疗实施指南.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 7, p. 667, doi. 10.3760/cma.j.cn112152-20211221-00959

By:

石远凯

Publication type:

Article

非转移性结直肠癌患者术后预后影响因素分析及列线图预测模型的构建.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 2, p. 167, doi. 10.3760/cma.j.cn112152-20200321-00244

By:

刘书霞;
张磊;
石远凯;
韩晓红

Publication type:

Article

内科肿瘤住院患者静脉血栓栓塞症的风险与防控现状.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 10, p. 1100, doi. 10.3760/cma/j.cn112152-20210607-00437

By:

徐瑞华;
石远凯;
高远;
李为民;
秦新裕;
瞿介明;
翟振国;
王辰

Publication type:

Article

霍奇金淋巴瘤免疫逃逸机制及其临床应用价值.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 917, doi. 10.3760/cma.j.cn112152-20200623-00591

By:

陶云霞;
石远凯

Publication type:

Article

中国抗肿瘤新药临床试验60年发展历程和主要成果(1960—2020).

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 6, p. 696, doi. 10.3760/cma.j.cn112152-20210218-00139

By:

石远凯;
孙燕

Publication type:

Article

中国淋巴瘤治疗指南（2021年版).

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 7, p. 707, doi. 10.3760/cma.j.cnll2L52-20210516-00382

By:

石远凯

Publication type:

Article

肺癌脑转移中国治疗指南(2021年版).

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 3, p. 269, doi. 10.3760/cma.j.cn112152-20210104-00009

By:

石远凯

Publication type:

Article

中国淋巴瘤多学科诊疗模式实施指南.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 2, p. 163, doi. 10.3760/cma.j.cn112152?20201109-00971

By:

石远凯

Publication type:

Article

Ⅳ期原发性肺癌中国治疗指南（2021 年版).

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 1, p. 39, doi. 10.3760/cma.j.cn112152-20201009-00884

By:

石远凯

Publication type:

Article

程序性死亡受体１抑制剂联合利妥昔单抗方案治疗复发难治弥漫大Ｂ细胞淋巴瘤疗效和安全性的初步分析.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 12, p. 1034, doi. 10.3760/cma.j.cn112152?20200506?00410

By:

秦燕;
赵凤仪;
周钰;
姜时雨;
杨晟;
石远凯

Publication type:

Article

弥漫大Ｂ细胞淋巴瘤预后相关分子标志物的研究进展.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 12, p. 989, doi. 10.3760/cma.j.cn112152-20191125-00756

By:

陈海珠;
石远凯

Publication type:

Article

盐酸安罗替尼治疗晚期肺癌中国专家共识 (2020版).

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 10, p. 807, doi. 10.3760/cma.j.cnl12152-20200721-00669

By:

石远凯

Publication type:

Article

程序性细胞死亡蛋白１单抗联合化疗在 Ⅱ期和Ⅲ期非小细胞肺癌术前新辅助治疗中的疗效和安全性.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 6, p. 480, doi. 10.3760/cma.j.cn112152-20200213-00087

By:

刘雨桃;
高禹舜;
毛友生;
姜军;
杨琳;
杨建良;
胡兴胜;
周生余;
秦燕;
石远凯

Publication type:

Article

新型冠状病毒肺炎疫情期间肿瘤患者肺部浸润鉴别诊断.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 4, p. 305, doi. 10.3760/cma.j.cnl12152-20200303-00166

By:

朱闻捷;
王洁;
何小慧;
秦燕;
杨晟;
胡兴胜;
王宏羽;
黄镜;
周爱萍;
马飞;
石远凯;
周生余

Publication type:

Article

老年弥漫大Ｂ细胞淋巴瘤患者一线治疗方案疗效比较和预后分析.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 3, p. 234, doi. 10.3760/cma.j.cnl12152-20190705-00413

By:

刘鹏;
姜时雨;
何小慧;
秦燕;
桂琳;
周生余;
杨建良;
杨晟;
温霆宇;
石远凯

Publication type:

Article

晚期非小细胞肺癌表皮生长因子受体酪氨酸激酶抑制剂临床研发和审评考虑

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 12, p. 949, doi. 10.3760/cma.j.issn.0253-3766.2019.12.012

By:

周明;
陈东梅;
夏琳;
宋媛媛;
石远凯;
杨志敏

Publication type:

Article

Ⅳ期原发性肺癌中国治疗指南 (2020 年版).

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 1, p. 1, doi. 10.3760/cma.j.issn.0253-3766.2020.01.001

By:

石远凯

Publication type:

Article

头颈部鳞癌免疫检查点抑制治疗的研究进展.

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 9, p. 641, doi. 10.3760/cma.j.issn.0253-3766.2019.09.001

By:

黄莉玲;
石远凯

Publication type:

Article

中国原研抗肿瘤新药物的临床试验.

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 1, p. 68, doi. 10.3760/cma.j.issn.0253-3766.2019.01.012

By:

石远凯;
孙燕

Publication type:

Article

肺腺鳞癌的临床病理和分子生物学特征及其预后影响因素分析.

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 1, p. 50, doi. 10.3760/cma.j.issn.0253-3766.2019.01.009

By:

周生余;
薛奇;
应建明;
胡兴胜;
杨建良;
林华;
石远凯

Publication type:

Article

造血干细胞移植治疗淋巴瘤中国专家共识（2018 版）.

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 12, p. 927, doi. 10.3760/cma.j.issn.0253-3766.2018.12.011

By:

邱录贵;
李建勇;
石远凯

Publication type:

Article

表皮生长因子受体酪氨酸激酶抑制剂治疗肺腺鳞癌患者的疗效及影响因素

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 10, p. 776, doi. 10.3760/cma.j.issn.0253-3766.2018.10.010

By:

周生余;
胡兴胜;
李峻岭;
王燕;
刘雨桃;
邢镨元;
杨建良;
林华;
石远凯

Publication type:

Article

嵌合抗原受体修饰 T 细胞在实体肿瘤免疫治疗中的展望.

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 7, p. 490, doi. 10.3760/cma.j.issn.0253-3766.2018.07.002

By:

周生余;
石远凯

Publication type:

Article

３７0 例晚期弥漫大Ｂ细胞淋巴瘤的临床特征和预后分析.

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 6, p. 456, doi. 10.3760/cma.j.issn.0253-3766.2018.06.011

By:

韩颖;
秦燕;
何小慧;
杨建良;
刘鹏;
张长弓;
周立强;
周生余;
桂琳;
宋永文;
孙燕;
石远凯

Publication type:

Article

单臂试验支持抗肿瘤新药注册的考虑.

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 1, p. 58, doi. 10.3760/cma.j.issn.0253-3766.2018.01.011

By:

周明;
陈晓媛;
张虹;
夏琳;
仝昕;
邹丽敏;
郝瑞敏;
赵肖;
石远凯;
杨志敏

Publication type:

Article

生物类似药在肿瘤领域中的发展现状.

Published in:

Chinese Journal of Oncology, 2017, v. 39, n. 10, p. 721, doi. 10.3760/cma.j.issn.0253-3766.2017.10.001

By:

姜时雨;
石远凯

Publication type:

Article

化疗后预防性使用重组人粒细胞集落刺激因子的持续时间及其影响因素.

Published in:

Chinese Journal of Oncology, 2016, v. 38, n. 1, p. 69, doi. 10.3760/cma.j.issn.0253?3766.2016.01.013

By:

杨晟;
何小慧;
刘鹏;
周生余;
董梅;
秦燕;
杨建良;
张长弓;
韩晓红;
石远凯

Publication type:

Article

中国肺癌脑转移诊治专家共识（2017年版）.

Published in:

Chinese Journal of Lung Cancer, 2017, v. 20, n. 1, p. 1, doi. 10.3779/j.issn.1009-3419.2017.01.01

By:

石远凯;
孙燕;
于金明;
丁翠敏;
马智勇;
王子平;
王东;
王征;
王孟昭;
王燕;
卢铀;
艾斌;
冯继锋刘云鹏;
刘晓晴;
刘基巍;
伍钢;
曲宝林;
李学记;
李恩孝;
李薇

Publication type:

Article

西妥昔单抗联合化疗治疗晚期非小细胞肺癌的临床疗效分析.

Published in:

Chinese Journal of Lung Cancer, 2016, v. 19, n. 5, p. 263, doi. 10.3779/j.issn.1009-3419.2016.05.03

By:

杨晟;
王燕;
胡兴胜;
王宏羽;
郝学志;
许建萍;
汪麟;
王彬;
李峻岭;
赵龙妹;
姜培娣;
屈凤莲;
张湘茹;
石远凯

Publication type:

Article

中国晚期原发性肺癌诊治专家共识（2016年版）.

Published in:

Chinese Journal of Lung Cancer, 2016, v. 19, n. 1, p. 1, doi. 10.3779/j.issn.1009-3419.2016.01.01

By:

石远凯;
孙燕;
于金明;
丁翠敏;
王子平;
王长利;
王东;
王存德;
王征;
王孟昭;
支修益;
卢铀;
冯继锋;
刘云鹏;
刘晓晴;
刘巍;
伍钢;
李小梅;
李凯;
李恩孝

Publication type:

Article

中国埃克替尼治疗非小细胞肺癌专家共识（2015版）.

Published in:

2015

By:

石远凯;
孙燕;
丁翠敏;
王子平;
王长利;
王正;
白冲;
白春学;
冯继锋;
刘晓晴;
李方;
杨跃;
束永前;
吴密璐;
何建行;
张沂平;
张树才;
陈公琰;
罗红鹤;
罗荣城

Publication type:

journal article

初始易瑞沙治疗有效的晚期肺腺癌二次使用易瑞沙的疗效分析

Published in:

Chinese Journal of Lung Cancer, 2012, v. 15, n. 1, p. 44, doi. 10.3779/j.issn.1009-3419.2012.01.09

By:

李峻岭;
郝学志;
王燕;
张湘茹;
石远凯

Publication type:

Article

EGFR基因rs2293347多态对吉非替尼治疗非小细胞肺癌临床疗效的影响

Published in:

Chinese Journal of Lung Cancer, 2011, v. 14, n. 8, p. 642, doi. 10.3779/j.issn.1009-3419.2011.08.02

By:

马飞;
徐兵河;
林东昕;
孙瞳;
石远凯

Publication type:

Article

吉西他滨顺铂联合索拉非尼或安慰剂一线治疗晚期非小细胞肺癌的随机对照研究.

Published in:

Chinese Journal of Lung Cancer, 2011, v. 14, n. 3, p. 239, doi. 10.3779/j.issn.1009-3419.2011.03.10

By:

王燕;
汪麟;
刘雨桃;
于舒飞;
张湘茹;
石远凯;
孙燕

Publication type:

Article

细胞学标本间变性淋巴瘤激酶蛋白表达及基因融合检测规范化流程.

Published in:

Chinese Journal of Oncology, 2015, v. 37, n. 10, p. 742

By:

王征;
武晓楠;
石远凯;
韩晓红;
程刚;
李琳;
穆新林;
张予辉;
崔娣;
张力;
樊再雯;
朱广卿;
马凌云;
杨丽;
邸婧;
刘冬戈

Publication type:

Article

４１５例霍奇金淋巴瘤患者的疗效和预后因素分析.

Published in:

Chinese Journal of Oncology, 2015, v. 37, n. 6, p. 466, doi. 10.3760/cma.j.issn.0253?3766.2015.06.015

By:

陶云霞;
康愫意;
周立强;
石远凯;
李晔雄;
孙燕

Publication type:

Article